Last quarter, Wyndham Hotels & Resorts finally gave investors what they had been waiting for: evidence that US select-service demand had turned. Domestic RevPAR rose 2%, beating management's own 1% assumption. The company raised its full-year outlook for the first time after three quarters of flat or reduced guidance. The third-quarter report, due after the close on October 21, is where that turn either becomes a trend or gets exposed as a single good quarter.
The headline numbers will not look like a recovery story on their own. Analysts expect earnings of $1.31 per share, about 10% below last year's $1.46. Revenue is projected to rise 7.6% to roughly $410.9 million. That gap between top-line growth and a profit decline is not necessarily alarming. Management warned that some of the second quarter's EBITDA strength came from G&A timing and insurance recoveries that would reverse in the back half, and that most remaining growth is weighted toward the fourth quarter. Still, a shortfall here would put more pressure on an already back-loaded year.
Full-year guidance calls for earnings of $4.71 to $4.83 per share on revenue of $1.48 billion to $1.50 billion. The Street sits at $4.82, essentially at the top of that range, while its $1.49 billion revenue estimate lands at the midpoint. In other words, analysts are already giving Wyndham credit for executing close to perfectly on earnings. That leaves little room for another raise to impress unless the third quarter clearly beats expectations.
The most important number is US RevPAR. Management lifted its second-half domestic assumption from flat to up 2%, citing several supports. These include tax-refund-fueled leisure spending and midweek occupancy gains tied to infrastructure, AI data center and oil and gas work. Texas, California and Florida, roughly a quarter of US rooms, swung from an 11% decline late last year to a 4% gain in the second quarter. If those states hold their momentum and domestic RevPAR prints at or above 2%, the recovery thesis gets considerably sturdier. A slide back toward flat would undercut the very assumption that justified the guidance increase.
The international business is the counterweight. Overseas RevPAR fell 6% in constant currency last quarter, the Middle East collapsed 45%, Latin America weakened on softer US travel to Mexico, and China slipped 5%. The REVO insolvency in Europe also continues to wind down. Most of that portfolio is set to terminate in the third and fourth quarters, so unit counts and retention, which ran at 95% against a 96% target, deserve close attention. A record pipeline of about 261,000 rooms helps offset that attrition. Openings would need to keep pace with deletions for net room growth to hold up. Ancillary revenue is another tell. It rose 12% through midyear against a low-to-mid-teens full-year goal, which implies acceleration as the refreshed Barclays card lineup and AI tools like Wyndham Connect gain traction.
Sentiment has warmed noticeably, with bearishness easing from 36.3% before the last report to 15.5% now. The stock has not followed. Shares are down 1.7% since the July report while the S&P 500 gained 5.2%. At $73.35, the stock trades below its 200-day average of $78.09, in the upper half of a post-earnings range of $66.87 to $78.46, and well beneath the prior quarter's $74.55 to $88.36 band. The market seems to accept the operating improvement but has not yet been persuaded to pay for it.
Ultimately, this report comes down to whether domestic RevPAR growth near 2% proves durable enough to absorb international weakness and REVO run-off. If it does, the back-loaded guidance looks credible and the stock's lag may prove an opportunity. If it doesn't, the first guidance raise in a year could start to look premature.